Strathspey Crown Holdings subsidiary and social commerce firm Alphaeon has completed the acquisition of US-based commercial stage medical device firm, Lensar, for an undisclosed amount.

Established in 2004, Lensar is a developer and manufacturer of femtosecond laser systems (FLS) through a wholly owned subsidiary.

At the signing of the agreement in November, Alphaeon noted the transaction is valued at up to $59m in cash, stock and assumed debt.

The company developed the femtosecond cataract laser to enable automation of critical surgical procedure planning.

The Lensar laser system provides patients with better outcomes following the removal of their crystalline lens.

Alphaeon CEO Robert Grant said: "We are pleased to have closed the acquisition of Lensar.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"The advancements they have made in the self-pay category of precision refractive surgery complement our lifestyle product portfolio."

"The advancements they have made in the self-pay category of precision refractive surgery complement our lifestyle product portfolio, allowing ophthalmologists to offer another alternative to patients."

The acquisition allows Alphaeon to expand its ophthalmology business, offering advanced technology to its network of more than 4,200 board certified ophthalmologists worldwide.

Last December, Alphaeon also acquired Canada-based Clarion Medical Technologies for $55m.

Established in 1989, Clarion supplies medical and aesthetic equipment and consumables for hospitals and private practices in Canada. Formerly known as Coherent-AMT, Clarion has 100 employees, 36 sales representatives and more than 40 product licenses.

Alphaeon is a lifestyle healthcare firm that works with board certified physicians to provide new products and services.

Strathspey Crown is an equity firm specialising in lifestyle healthcare and its investors include board certified physician specialists across key medical specialties, comprising plastic surgery, ophthalmology, dermatology, dentistry and orthopaedics.

Image: Alphaeon Corporation in Irvine, California. Photo: courtesy of Alphaeon.